Austin pharm.co.Ltd. announced that i will issue 2,372,368 common shares at an issue price gross proceeds of KRW 9,963,945,600 on December 26, 2022. The transaction will include participation from BioSmart Co.,Ltd. The transaction has been approved by the board of directors of the company.